Phenomenology and classification of dystonia: a consensus update
A Albanese, K Bhatia, SB Bressman… - Movement …, 2013 - Wiley Online Library
This report describes the consensus outcome of an international panel consisting of
investigators with years of experience in this field that reviewed the definition and …
investigators with years of experience in this field that reviewed the definition and …
Postural instability in patients with Parkinson's disease: Epidemiology, pathophysiology and management
Postural instability is one of the cardinal signs in Parkinson's disease (PD). It can be present
even at diagnosis, but becomes more prevalent and worsens with disease progression. It …
even at diagnosis, but becomes more prevalent and worsens with disease progression. It …
Levodopa dose equivalency in Parkinson's disease: updated systematic review and proposals
ST Jost, MA Kaldenbach, A Antonini… - Movement …, 2023 - Wiley Online Library
Background To compare drug regimens across clinical trials in Parkinson's disease (PD)
conversion formulae between antiparkinsonian drugs have been developed. These are …
conversion formulae between antiparkinsonian drugs have been developed. These are …
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
S Ramanathan, S Mohammad, E Tantsis… - Journal of Neurology …, 2018 - jnnp.bmj.com
Objective We characterised the clinical course, treatment and outcomes in 59 patients with
relapsing myelin oligodendrocyte glycoprotein (MOG) antibody-associated demyelination …
relapsing myelin oligodendrocyte glycoprotein (MOG) antibody-associated demyelination …
Clinical and physiological assessments for elucidating falls risk in Parkinson's disease
MD Latt, SR Lord, JGL Morris… - … disorders: official journal …, 2009 - Wiley Online Library
The study aims were to devise (1) a fall risk screen for people with PD using routine clinical
measures and (2) an explanatory (physiological) fall risk assessment for guiding fall …
measures and (2) an explanatory (physiological) fall risk assessment for guiding fall …
[HTML][HTML] Impact of the COVID‐19 pandemic on Parkinson's disease and movement disorders
Human coronaviruses have classically caused mild respiratory infections. Two previous
outbreaks caused by newly identified coronaviruses, SARS-CoV in 2002 and MERS-CoV in …
outbreaks caused by newly identified coronaviruses, SARS-CoV in 2002 and MERS-CoV in …
Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis
S Ramanathan, K Prelog, EH Barnes… - Multiple Sclerosis …, 2016 - journals.sagepub.com
Background: Recognizing the cause of optic neuritis (ON) affects treatment decisions and
visual outcomes. Objective: We aimed to define radiological features of first-episode …
visual outcomes. Objective: We aimed to define radiological features of first-episode …
Exercise for falls prevention in Parkinson disease: a randomized controlled trial
Objective: To determine whether falls can be prevented with minimally supervised exercise
targeting potentially remediable fall risk factors, ie, poor balance, reduced leg muscle …
targeting potentially remediable fall risk factors, ie, poor balance, reduced leg muscle …
The effects of an exercise program on fall risk factors in people with Parkinson's disease: a randomized controlled trial
NE Allen, CG Canning, C Sherrington… - Movement …, 2010 - Wiley Online Library
This randomized controlled trial with blinded assessment aimed to determine the effect of a
6‐month minimally supervised exercise program on fall risk factors in people with …
6‐month minimally supervised exercise program on fall risk factors in people with …
Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: final 12‐month, open‐label results
Motor complications in Parkinson's disease (PD) are associated with long‐term oral
levodopa treatment and linked to pulsatile dopaminergic stimulation. l‐dopa‐carbidopa …
levodopa treatment and linked to pulsatile dopaminergic stimulation. l‐dopa‐carbidopa …